Open Access

Anaplastic thyroid cancer with long‑term survival with lenvatinib therapy and preservation of laryngeal function after one‑stage reconstruction: A case report

  • Authors:
    • Akihisa Tanaka
    • Hirokazu Uemura
    • Takashi Masui
    • Shigenori Kanazawa
    • Yumi Yoshii
    • Masatoshi Kanno
    • Gohei Morita
    • Chiho Obayashi
    • Toshiaki Yamanaka
    • Tadashi Kitahara
  • View Affiliations

  • Published online on: June 11, 2021     https://doi.org/10.3892/mco.2021.2320
  • Article Number: 158
  • Copyright : © Tanaka et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Laryngotracheal reconstruction is performed to treat locally advanced thyroid carcinoma invading the larynx and/or trachea. The reconstructive technique varies. The present report describes the case of a 71‑year‑old female patient who underwent surgery for thyroid carcinoma involving the larynx. Reconstructive surgical techniques were employed to maintain laryngeal structure and function. An anterolateral thigh flap with free rib cartilage grafts was used to compensate for laryngeal defects. Although a temporary tracheal stoma was constructed, it closed spontaneously after decannulation. Therefore, one‑stage laryngeal reconstruction was accomplished. Post‑operative histopathological examination revealed focal anaplastic changes in the lesion, which mainly consisted of papillary components. Post‑operative positron emission tomography/computed tomography indicated early recurrence in the left side of the neck. Therefore, lenvatinib was started as adjuvant therapy. Complete response was observed with lenvatinib therapy. The patient was alive and had good laryngeal function 26 months after the operation. One‑stage laryngeal reconstruction can reduce burden and improve quality of life in patients with thyroid carcinoma involving the larynx. Lenvatinib may be useful for treating early recurrence of anaplastic thyroid carcinoma after reconstructive surgery with a free flap.
View Figures
View References

Related Articles

Journal Cover

August-2021
Volume 15 Issue 2

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Tanaka A, Uemura H, Masui T, Kanazawa S, Yoshii Y, Kanno M, Morita G, Obayashi C, Yamanaka T, Kitahara T, Kitahara T, et al: Anaplastic thyroid cancer with long‑term survival with lenvatinib therapy and preservation of laryngeal function after one‑stage reconstruction: A case report. Mol Clin Oncol 15: 158, 2021
APA
Tanaka, A., Uemura, H., Masui, T., Kanazawa, S., Yoshii, Y., Kanno, M. ... Kitahara, T. (2021). Anaplastic thyroid cancer with long‑term survival with lenvatinib therapy and preservation of laryngeal function after one‑stage reconstruction: A case report. Molecular and Clinical Oncology, 15, 158. https://doi.org/10.3892/mco.2021.2320
MLA
Tanaka, A., Uemura, H., Masui, T., Kanazawa, S., Yoshii, Y., Kanno, M., Morita, G., Obayashi, C., Yamanaka, T., Kitahara, T."Anaplastic thyroid cancer with long‑term survival with lenvatinib therapy and preservation of laryngeal function after one‑stage reconstruction: A case report". Molecular and Clinical Oncology 15.2 (2021): 158.
Chicago
Tanaka, A., Uemura, H., Masui, T., Kanazawa, S., Yoshii, Y., Kanno, M., Morita, G., Obayashi, C., Yamanaka, T., Kitahara, T."Anaplastic thyroid cancer with long‑term survival with lenvatinib therapy and preservation of laryngeal function after one‑stage reconstruction: A case report". Molecular and Clinical Oncology 15, no. 2 (2021): 158. https://doi.org/10.3892/mco.2021.2320